Richard W. Paul & Associates’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.9K Buy
90
+1
+1% +$277 0.01% 207
2026
Q1
$26.3K Buy
89
+31
+53% +$9.21K 0.01% 195
2025
Q4
$15.8K Buy
+58
New +$15.8K 0.01% 208

Other funds holding CME

Richard W. Paul & Associates's CME Position: Q2 2026 in Review

Richard W. Paul & Associates increased its CME Group (CME) stake by 1.1% in Q2 2026, buying an estimated $277 and bringing the position to 90 shares worth $19.9K. The position accounts for 0.01% of the portfolio, ranked #207.

Richard W. Paul & Associates first reported a position in CME in Q4 2025 and has held it in 3 quarters since. The position peaked at $26.3K in Q1 2026. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Richard W. Paul & Associates held 90 shares of CME Group worth $19.9K as of Q2 2026.
  • Richard W. Paul & Associates bought 1 CME Group share in Q2 2026, an estimated $277.
  • CME Group made up 0.01% of Richard W. Paul & Associates's portfolio in Q2 2026, its #207 holding.
  • Richard W. Paul & Associates first reported a position in CME Group in Q4 2025 and has held it in 3 quarters since.
  • Richard W. Paul & Associates's CME Group position peaked at $26.3K in Q1 2026.
  • 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Richard W. Paul & Associates's 13F filing for Q2 2026, filed 10 Aug 2026.